Cambrex

Cambrex (CBM) stock price, revenue and financials

View Company

$1.4 B

CBM Mkt cap, 16-Jan-2019

$104 M

Cambrex Revenue Q3, 2018
Cambrex Gross profit (Q3, 2018)32.1 M
Cambrex Gross profit margin (Q3, 2018), %30.9%
Cambrex Net income (Q3, 2018)26.7 M
Cambrex EBIT (Q3, 2018)6.6 M
Cambrex Cash, 30-Sep-201897.1 M
Cambrex EV1.7 B

Cambrex Revenue

Cambrex revenue was $523.94 m in FY, 2017

Embed Graph

Cambrex Income Statement

Annual

USDFY, 2013FY, 2015FY, 2016FY, 2017

Revenue

315.9m431.9m489.2m523.9m

Cost of goods sold

215.3m256.4m286.4m304.4m

Gross profit

100.6m175.5m202.8m219.6m

Gross profit Margin, %

32%41%41%42%

R&D expense

10.4m12.5m14.3m16.9m

General and administrative expense

47.6m57.9m60.4m70.5m

Operating expense total

58.0m70.4m74.7m87.4m

EBIT

49.6m91.0m128.4m142.7m

EBIT margin, %

16%21%26%27%

Interest expense

2.2m1.7m717.0k1.3m

Pre tax profit

45.0m89.6m127.5m141.8m

Income tax expense

38.1m

Net Income

25.9m57.2m81.7m102.5m

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Revenue

77.4m65.6m97.3m80.6m77.7m106.0m91.7m93.4m118.2m99.3m103.1m133.8m112.0m138.9m147.0m104.0m

Cost of goods sold

52.5m49.5m64.5m52.9m48.4m60.7m57.3m55.8m70.1m61.8m58.2m77.1m65.7m90.2m87.3m71.9m

Gross profit

25.0m16.1m32.9m27.7m29.3m45.3m34.4m37.6m48.1m37.5m44.9m56.8m46.3m48.7m59.8m32.1m

Gross profit Margin, %

32%25%34%34%38%43%38%40%41%38%44%42%41%35%41%31%

R&D expense

2.6m2.5m3.6m3.8m2.7m2.7m3.7m3.5m4.1m3.2m3.9m4.5m4.2m3.6m4.1m4.2m

General and administrative expense

11.1m11.6m14.6m12.5m13.8m14.1m14.0m14.0m13.6m15.0m15.8m18.5m17.6m16.9m16.0m14.5m

Operating expense total

13.7m14.1m18.2m16.4m16.4m16.8m17.7m17.5m17.7m18.1m19.6m22.9m21.8m20.5m20.1m26.1m

EBIT

11.3m2.5m15.2m12.0m12.7m29.2m18.0m21.4m30.8m19.5m27.2m34.6m25.1m30.4m44.7m6.6m

EBIT margin, %

15%4%16%15%16%28%20%23%26%20%26%26%22%22%30%6%

Interest expense

664.0k522.0k543.0k570.0k476.0k474.0k517.0k366.0k337.0k82.0k17.0k725.0k

Pre tax profit

10.1m1.6m10.4m11.4m12.1m28.9m17.2m21.4m30.6m19.2m26.9m34.3m24.8m30.0m49.6m11.4m

Income tax expense

3.8m454.0k(9.4m)3.8m6.6m9.8m5.4m5.8m9.2m7.5m5.8m8.7m(15.4m)

Net Income

3.6m982.0k19.7m8.8m8.0m19.7m11.7m14.6m20.5m9.2m19.9m25.0m17.3m24.1m40.4m26.7m

Cambrex Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

22.7m45.5m44.0m74.1m183.3m

Accounts Receivable

12.9m10.6m7.3m6.7m

Inventories

90.0m8.7m109.9m123.2m138.5m

Current Assets

202.6m227.6m259.3m322.7m422.1m

PP&E

172.0m163.6m186.5m217.1m254.3m

Goodwill

38.7m43.9m32.1m40.3m43.6m

Total Assets

458.0m487.1m505.5m611.9m740.6m

Accounts Payable

29.1m43.7m39.3m42.9m35.0m

Short-term debt

Current Liabilities

97.3m98.8m129.8m95.5m82.5m

Long-term debt

79.3m60.0m

Total Debt

79.3m

Total Liabilities

247.8m194.7m206.4m195.7m

Additional Paid-in Capital

109.8m119.3m132.0m153.7m166.0m

Retained Earnings

131.2m188.5m245.7m327.4m429.8m

Total Equity

210.2m251.2m310.8m405.4m544.9m

Financial Leverage

2.2 x1.9 x1.6 x1.5 x1.4 x

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Cash

25.1m21.8m19.5m26.5m62.6m60.2m85.6m52.5m90.7m99.2m94.2m118.4m187.6m171.3m97.1m

Accounts Receivable

54.0m41.7m69.8m45.6m46.8m38.8m47.3m67.7m38.0m68.7m99.1m81.8m55.2m100.2m71.6m

Inventories

101.4m98.7m103.0m101.4m127.1m130.9m131.6m140.1m143.9m151.5m156.6m164.9m104.5m99.6m103.6m

Current Assets

198.7m182.2m213.0m194.4m253.4m246.0m283.8m279.9m289.0m332.8m366.2m378.1m462.7m504.2m416.8m

PP&E

167.0m169.6m170.2m162.3m172.4m180.6m203.6m204.2m209.2m223.8m237.8m248.9m270.4m266.1m352.9m

Goodwill

38.0m38.7m47.8m45.1m41.7m41.4m33.2m32.6m32.7m40.7m42.3m43.2m44.4m42.9m271.4m

Total Assets

466.4m444.7m476.1m444.3m512.9m509.7m544.2m536.9m555.1m627.5m673.1m698.4m796.2m830.9m1.2b

Accounts Payable

32.0m26.9m28.5m34.0m42.1m52.7m39.3m36.6m36.8m38.8m39.1m39.9m43.9m51.6m38.2m

Current Liabilities

86.8m91.9m98.1m89.3m108.9m123.3m104.5m80.7m78.9m84.9m88.4m84.2m91.8m96.4m91.8m

Long-term debt

101.1m60.0m74.0m60.0m60.0m30.0m325.0m

Total Debt

101.1m60.0m74.0m60.0m60.0m30.0m325.0m

Total Liabilities

280.1m231.3m240.5m211.9m240.4m223.2m209.1m183.8m188.1m197.0m202.5m200.5m203.5m207.6m588.6m

Additional Paid-in Capital

107.5m112.0m113.5m116.5m123.8m126.9m133.2m136.8m141.1m154.9m159.4m162.1m170.3m172.5m181.4m

Retained Earnings

122.3m132.2m151.8m160.6m216.1m227.9m260.3m280.8m290.0m347.2m372.3m389.6m470.1m510.5m537.3m

Total Equity

186.3m213.3m235.5m232.4m272.5m286.4m335.1m353.1m366.9m430.5m470.6m497.9m592.7m623.3m659.3m

Debt to Equity Ratio

0.5 x0.5 x

Debt to Assets Ratio

0.2 x0.3 x

Financial Leverage

2.5 x2.1 x2 x1.9 x1.9 x1.8 x1.6 x1.5 x1.5 x1.5 x1.4 x1.4 x1.3 x1.3 x1.9 x

Cambrex Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

25.9m57.3m57.2m81.7m102.5m

Depreciation and Amortization

22.5m23.8m22.1m24.7m31.8m

Accounts Receivable

Inventories

(19.3m)(9.1m)(32.7m)(23.7m)(13.3m)

Accounts Payable

10.1m12.4m10.3m1.8m(20.1m)

Cash From Operating Activities

36.9m65.0m83.6m123.3m149.0m

Cash From Investing Activities

(56.6m)(24.8m)(60.2m)(74.0m)(49.3m)

Cash From Financing Activities

18.2m(14.5m)(22.7m)(17.3m)4.8m

Free Cash Flow

(20.4m)88.3m21.1m73.6m96.9m

Quarterly

USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018

Net Income

17.0m982.0k20.6m29.4m8.0m27.7m39.4m14.6m35.1m44.3m19.9m44.9m62.2m24.1m64.5m91.2m

Depreciation and Amortization

16.6m5.9m11.8m17.9m5.3m10.7m16.3m5.6m11.3m17.7m7.2m14.8m23.0m7.5m15.0m24.2m

Accounts Receivable

81.8m

Inventories

(31.6m)(10.0m)(16.5m)(22.2m)(29.0m)(46.5m)(52.5m)(21.0m)(35.0m)(40.1m)(28.2m)(31.2m)(38.2m)(58.0k)(1.0m)1.7m

Accounts Payable

7.4m(3.7m)1.4m8.1m(2.2m)2.7m13.8m4.0m(12.4m)(11.5m)(10.0m)(13.2m)(16.4m)4.1m10.2m(17.5m)

Cash From Operating Activities

(1.7m)24.6m12.5m41.4m35.4m40.2m80.0m89.8m64.6m111.8m36.0m37.1m72.1m24.5m17.5m39.8m

Cash From Investing Activities

(35.5m)(7.6m)(12.0m)(20.2m)(12.0m)(23.5m)(37.5m)(19.8m)(26.5m)(37.7m)(12.2m)(22.9m)(35.4m)(23.8m)(32.7m)(462.5m)

Long-term Borrowings

(30.0m)(30.0m)(30.0m)

Cash From Financing Activities

38.4m(17.9m)(3.5m)(15.3m)1.6m2.2m(26.2m)(29.2m)(29.8m)(27.4m)725.0k3.0m3.4m2.7m4.6m337.7m

Free Cash Flow

(38.1m)17.0m3.1m23.3m22.7m14.6m40.3m69.9m38.1m74.1m23.8m14.2m33.8m660.0k(15.2m)(3.8m)

Cambrex Ratios

USDY, 2018

EV/EBIT

249.5 x

EV/CFO

41.6 x

EV/FCF

-437.6 x

Debt/Equity

0.5 x

Debt/Assets

0.3 x

Financial Leverage

1.9 x
Download Excel
Report incorrect company information

Cambrex Employee Rating

2.523 votes
Culture & Values
2.6
Work/Life Balance
2.7
Senior Management
2.2
Salary & Benefits
3.4
Career Opportunities
2.2
Source
View Cambrex profile

Competitors

Lonza
Healthcare - Public
Assertio Therapeutics
Healthcare - Public
Aradigm
Healthcare - Public
Albany Molecular Research
Healthcare - Subsidiary
Compare competitors